Rekombinanter CD40L (Ruplizumab Biosimilar) Antikörper

Produktnummer ABIN7093061

Produktdetails anti-CD40L (Ruplizumab Biosimilar) Antikörper

Target: CD40L (Ruplizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Humanized

Klonalität: Monoklonal

Konjugat: Dieser CD40L (Ruplizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), ELISA

Verwendungszweck: Anti-CD40L (ruplizumab biosimilar) mAb

Produktmerkmale: BG-9588, hu5c8

Aufreinigung: Purified from cell culture supernatant by affinity chromatography

Güteklasse: Research Grade

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: ELISA 1:5000-10000, Flow Cyt 1:100

Kommentare:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Haltbarkeit: 12 months

Details zu CD40L (Ruplizumab Biosimilar)

Target: CD40L (Ruplizumab Biosimilar)

Abstract: CD40L (Ruplizumab Biosimilar) Produkte

Synonyme: CD154 antikoerper, CD40L antikoerper, HIGM1 antikoerper, IGM antikoerper, IMD3 antikoerper, T-BAM antikoerper, TNFSF5 antikoerper, TRAP antikoerper, gp39 antikoerper, hCD40L antikoerper, CD40 ligand antikoerper, CD40LG antikoerper

Substanzklasse: Biosimilar

Hintergrund: Synonyms: CD40LG,CD154,CD40L,HIGM1,IGM,IMD3,T-BAM,TNFSF5,TRAP,gp39

Gen-ID: 959

UniProt: P29965